Enlightenment through smart measurements

Open menu

News & Events

OpSens Announces First Quarter fiscal 2021 financial Results

13 January 2021

OpSens Announces First Quarter fiscal 2021 financial Results Quebec City, Quebec, January 13, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering diagnostic and treatment solutions based on its proprietary optical technology, today reported its financial results for the first quarter of fiscal 2021, ended November 30, 2020….

Read more

OpSens to Host First Quarter Fiscal Year 2021 Financial Results Conference Call on Wednesday, January 13, 2021

6 January 2021

OpSens to Host First Quarter Fiscal Year 2021 Financial Results Conference Call on Wednesday, January 13, 2021   Conference call to be conducted at 11:00 am ET Quebec City, Quebec, January 6, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering diagnostic and treatment solutions based on its…

Read more

OpSens to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference

24 November 2020

OpSens to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference Quebec City, Quebec, November 24, 2020 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering diagnostic and treatment solutions based on its proprietary optical technology, is presenting at the Piper Sandler 32nd Annual Virtual Healthcare Conference, and…

Read more

OpSens announces fourth quarter and fiscal year 2020 results

19 November 2020

OpSens Announces Fourth Quarter And Fiscal Year 2020 Financial Results Quebec City, Quebec, November 19, 2020 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today reported its results for the fourth quarter and fiscal year 2020 ended August 31, 2020. Financial Highlights Sales of product at $29.5 million in FY 2020 compared to prior…

Read more

OpSens recognized as one of the Fastest-Growing Companies in North America on Deloitte’s 2020 Technology Fast 500™

18 November 2020

OpSens recognized as one of the Fastest-Growing Companies in North America on Deloitte’s 2020 Technology Fast 500™ Quebec City, Quebec, November 18, 2020 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF),  a medical device cardiology-focused company commercializing a second-generation fiber optic pressure guidewire to diagnose and treat coronary disease, has been recognized in Deloitte’s…

Read more

OpSens to Present at the Virtual Fall Investor Summit On November 16

13 November 2020

Access OpSens’ presentation

OpSens to Host Year-End Update Conference Call on Thursday, November 19, 2020

12 November 2020

OpSens to Host Year-End Update Conference Call on Thursday, November 19, 2020 Conference call to be conducted on November 19, 2020 at 11:00 am ET Quebec City, Quebec, November 12, 2020 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company commercializing a  second generation fiber optic pressure guidewire to diagnose…

Read more

OpSens to Present at the Virtual Fall Investor Summit On November 16

10 November 2020

OpSens to Present at the Virtual Fall Investor Summit On November 16 Quebec City, Quebec, November 10, 2020 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering diagnostic and treatment solutions based on its proprietary optical technology, will present at the Virtual Fall Investor Summit on Monday, November 16, 2020 at…

Read more

OpSens Awarded Contract by Major U.S. Group Purchasing Organization

14 October 2020

OPSENS AWARDED CONTRACT BY MAJOR U.S. GROUP PURCHASING ORGANIZATION OptoWire gains access to more than 50 PCI centers Quebec City, Quebec, October 14, 2020 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF),  a medical device cardiology-focused company commercializing a  second-generation fiber optic pressure guidewire to diagnose and treat coronary disease, announced today it has been…

Read more

OpSens Announces Q3 Results 2020

15 July 2020

Quebec City, Quebec, July 15, 2020 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today reported its results for the third quarter of 2020. Highlights Net earnings of $0.1 M for the third quarter ended May 31, 2020 compared with a net loss of $1.1 M for the corresponding period in 2019; Consolidated revenues of…

Read more